HOYA Vision Care Launches New Stock Lens Outlet for ECPs
LensesByHoya.us offers competitive pricing, wide product availability, quick shipping, and an easy order experience for stock lenses. LEWISVILLE, Texas, Sept. 4,... Read more.
The Great Reassessment: A New Driver in Franchising According to The Perfect Franchise
SHOHOLA, Pa., Sept. 4, 2025 /PRNewswire/ — The Perfect Franchise (TPF), a leading franchise consulting firm, today announced new insights into the evolution... Read more.
GOLDMAN SACHS AND T. ROWE PRICE ANNOUNCE STRATEGIC COLLABORATION TO DELIVER INNOVATIVE PUBLIC-PRIVATE INVESTMENT SOLUTIONS
Firms will broaden access to diversified public and private market portfolios with a focus on retirement and wealth channels BALTIMORE and NEW YORK, Sept. 4, 2025... Read more.
Aurzen Debuts ZIP Cyber Edition Projector at IFA 2025
Aurzen ZIP Cyber Edition — The Future in Your Pocket, The Moment to Share. BERLIN, Sept. 4, 2025 /PRNewswire/ — Aurzen today announced the global unveiling... Read more.
Thomson Reuters Establishes Automatic Share Purchase Plan
TORONTO, Sept. 4, 2025 /PRNewswire/ — Thomson Reuters (TSX/Nasdaq: TRI), a global content and technology company, today announced that, in connection with... Read more.
Biozen Presents Calibration-Free, Cuffless Blood Pressure Technology at AHA 2025
Absolute blood pressure monitoring technology to be presented at the American Heart Association Hypertension Scientific Sessions OKLAHOMA CITY, Sept. 4, 2025 /PRNewswire/... Read more.
Despite 7 in 8 Ecommerce Brands Raising Prices to Offset Tariffs, 96% Still Expect International Sales to Rise in Q4
Passport’s Peak Season original research—released alongside its new Winning the U.S. Market report—exposes the execution gap, with only 31% of leaders... Read more.
Satellite Payload Market worth $11.44 billion in 2030 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Sept. 4, 2025 /PRNewswire/ — The satellite payload market is projected to be USD 11.44 billion in 2030 from USD 6.07 billion in 2025 at... Read more.
Lilly’s olomorasib receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers
The Breakthrough Therapy designation for olomorasib is based on data from the Phase 1/2 LOXO-RAS-20001 trial and Phase 3 SUNRAY-01 trial Updated efficacy and safety... Read more.
Hyperscale Data Subsidiary Ault Markets Advances Development of StableShare, an Artificial Intelligence Powered Platform for Tokenized Securities
LAS VEGAS, Sept. 4, 2025 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company“),... Read more.